...characterization and clinical testing of the SMAs. KSB.L will retain commercial rights to the antibodies. KS Biomedix Holdings Plc...

...India; and Medison in Israel. Celtic subsidiary Xenova gained TransMID through its 2003 acquisition of KS Biomedix...

...Petach Tikva, Israel) for Israel. Celtic subsidiary Xenova gained TransMID through its 2003 acquisition of KS Biomedix...

...in the firm's new Toronto office. Previously, Midmer was on the business development side at KS BioMedix...

...Vancouver, B.C. Business: Cancer Hired: Fahar Merchant as VP of corporate development, formerly CTO of KS Biomedix...

...recurrent glioblastoma multiforme. The sale finishes XEN's restructuring program, which began after the company acquired KS Biomedix...

...months following completion. The sale completes XEN's restructuring program, which began after XEN's acquisition of KS Biomedix...

...is a modified diphtheria toxin conjugated to transferrin that XEN obtained through its acquisition of KS Biomedix...

...XEN gained TransMID, a modified diphtheria toxin conjugated to transferrin , through its acquisition of KS Biomedix...

...The trial has an SPA with FDA. XEN acquired TransMID through its 2003 acquisition of KS Biomedix Holdings plc...